About Kyle Rusconi
Kyle Rusconi is a director at Gliknik.
Kyle Rusconi first appears on SEC filings in 2023.
Experience
This experience comes from Kyle Rusconi's profile and from SEC filings. For roles taken from filings, the years are when the filings name Kyle Rusconi in the role, so the role may have started earlier or lasted longer.
Gliknik Inc Current
Member Board of Directors - Director , Audit Chair
2021 – Present · Baltimore, MD
Develops biologic drugs for people with cancer and immune disorders.
FL
First In Ventures, LLC Current
Co-Founder & Venture Partner
2020 – Present
CI
Celldom, Inc.
Member Board of Directors -Observer
2023 – 2026
SC
Sharpen.com
Member Board of Directors, Co-Founder & CFO
2018 – 2025
DH
Doubling Road Holdings
Partner
2013 – 2018
MG
Macquarie Group
Global Head of Quantitative, Fundamental, Global Macro Proprietary Trading
2010 – 2013
BC
BNP Paribas CIB
US Head of Proprietary Trading
1995 – 2010
Key Colleagues at Startups
The people Kyle Rusconi works with at each company, as listed on that company's latest Form D.
Gliknik Inc · Form D/A, Sep 17, 2026
PF
Paul Freidman
Director
CP
Charles Polsky
Director
RS
Raymond Schinazi
Board Member
DB
David Broser
Director
EB
Elizabeth Block
Executive officer
RL
Richard Levy
Director
DB
David Block
Co-Founder & CEO, director